{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:17:48Z","timestamp":1791940668866,"version":"4.3.4"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s12185-009-0481-4","type":"journal-article","created":{"date-parts":[[2010,1,6]],"date-time":"2010-01-06T05:10:27Z","timestamp":1262754627000},"page":"20-29","source":"Crossref","is-referenced-by-count":61,"title":["Pivotal role of ADAMTS13 function in liver diseases"],"prefix":"10.1007","volume":"91","author":[{"given":"Masahito","family":"Uemura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saiho","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,7]]},"reference":[{"key":"481_CR1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccc.2005.03.002","volume":"21","author":"JL Kujovich","year":"2005","unstructured":"Kujovich JL. Hemostatic defects in end stage liver disease. Crit Care Clin. 2005;21:563\u201387.","journal-title":"Crit Care Clin"},{"key":"481_CR2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1538-7836.2007.02772.x","volume":"6","author":"PG Northup","year":"2008","unstructured":"Northup PG, Sundaram V, Fallon MB, Reddy KR, Balogun RA, Sanyal AJ, et al. Hypercoagulation and thrombophilia in liver disease. J Thromb Haemost. 2008;6:2\u20139.","journal-title":"J Thromb Haemost"},{"key":"481_CR3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","volume":"347","author":"JL Moake","year":"2002","unstructured":"Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347:589\u201399.","journal-title":"N Engl J Med"},{"key":"481_CR4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF02981975","volume":"75","author":"Y Fujimura","year":"2002","unstructured":"Fujimura Y, Matsumoto M, Yagi H, Yoshioka A, Matsui T, Titani K. Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome. Int J Hematol. 2002;75:25\u201334.","journal-title":"Int J Hematol"},{"key":"481_CR5","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/35097008","volume":"413","author":"GG Levy","year":"2001","unstructured":"Levy GG, Nichols WC, Lian EC, Foroud T, McClintick JN, McGee BM, et al. Mutations in a member of the ADAMTS13 gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413:488\u201394.","journal-title":"Nature"},{"key":"481_CR6","doi-asserted-by":"crossref","first-page":"11902","DOI":"10.1073\/pnas.172277399","volume":"99","author":"K Kokame","year":"2002","unstructured":"Kokame K, Matsumoto M, Soejima K, Yagi H, Ishizashi H, Funato M, et al. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Proc Natl Acad Sci USA. 2002;99:11902\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"481_CR7","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","volume":"339","author":"M Furlan","year":"1998","unstructured":"Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic\u2013uremic syndrome. N Engl J Med. 1998;339:1578\u201384.","journal-title":"N Engl J Med"},{"key":"481_CR8","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","volume":"339","author":"HM Tsai","year":"1998","unstructured":"Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339:1585\u201394.","journal-title":"N Engl J Med"},{"key":"481_CR9","first-page":"636a","volume":"96","author":"M Matsumoto","year":"2000","unstructured":"Matsumoto M, Chisuwa H, Nakazawa Y, Ikegami T, Hashikura Y, Kawasaki S, et al. Living-related liver transplantation rescues reduced vWF-cleaving protease activity in patients with cirrhotic biliary atresia. Blood. 2000;96:636a. (abstr.).","journal-title":"Blood"},{"key":"481_CR10","doi-asserted-by":"crossref","first-page":"41059","DOI":"10.1074\/jbc.C100515200","volume":"276","author":"X Zheng","year":"2001","unstructured":"Zheng X, Chung D, Takayama TK, Majerus EM, Sadler JE, Fujikawa K. Structure of von Willebrand factor-cleaving protease (ADAMTS 13), metalloproteinase involved in thrombotic thrombocytopenic purpura. J Biol Chem. 2001;276:41059\u201363.","journal-title":"J Biol Chem"},{"key":"481_CR11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/oxfordjournals.jbchem.a003009","volume":"130","author":"K Soejima","year":"2001","unstructured":"Soejima K, Mimura N, Hirashima M, Maeda H, Hamamoto T, Nakagaki T, et al. A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease? J Biochem. 2001;130:475\u201380.","journal-title":"J Biochem"},{"key":"481_CR12","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1182\/blood-2005-01-0152","volume":"106","author":"M Uemura","year":"2005","unstructured":"Uemura M, Tatsumi K, Matsumoto M, Fujimoto M, Matsuyama T, Ishikawa M, et al. Localization of ADAMTS13 to the stellate cells of human liver. Blood. 2005;106:922\u20134.","journal-title":"Blood"},{"key":"481_CR13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.bbrc.2003.11.111","volume":"313","author":"M Suzuki","year":"2004","unstructured":"Suzuki M, Murata M, Matsubara Y, Uchida T, Ishihara H, Shibano T, et al. Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets. Biochem Biophys Res Commun. 2004;313:212\u20136.","journal-title":"Biochem Biophys Res Commun"},{"key":"481_CR14","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/j.1538-7836.2006.01959.x","volume":"4","author":"N Turner","year":"2006","unstructured":"Turner N, Nolasco L, Tao Z, Dong JF, Moake J. Human endothelial cells synthesize and release ADAMTS-13. J Thromb Haemost. 2006;4:1396\u2013404.","journal-title":"J Thromb Haemost"},{"key":"481_CR15","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1365-2141.2007.06694.x","volume":"138","author":"M Manea","year":"2007","unstructured":"Manea M, Kristoffersson A, Schneppenheim R, Saleem MA, Mathieson PW, M\u00f6rgelin M, et al. Podocytes express ADAMTS13 in normal renal cortex and in patients with thrombotic thrombocytopenic purpura. Br J Haematol. 2007;138:651\u201362.","journal-title":"Br J Haematol"},{"key":"481_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-56553-3_1","volume":"161","author":"Z Kmie\u0107","year":"2001","unstructured":"Kmie\u0107 Z. Cooperation of liver cells in health and disease. Adv Anat Embryol Cell Biol. 2001;161:1\u2013151.","journal-title":"Adv Anat Embryol Cell Biol"},{"key":"481_CR17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1055\/s-2001-17551","volume":"21","author":"DC Rockey","year":"2001","unstructured":"Rockey DC. Hepatic blood flow regulation by stellate cells in normal and injured liver. Semin Liver Dis. 2001;21:337\u201348.","journal-title":"Semin Liver Dis"},{"key":"481_CR18","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/BF02781922","volume":"26","author":"M Hattori","year":"1991","unstructured":"Hattori M, Fukuda Y, Imoto M, Koyama Y, Nakano I, Urano F. Histochemical properties of vascular and sinusoidal endothelial cells in liver diseases. Gastroenterol Jpn. 1991;26:336\u201343.","journal-title":"Gastroenterol Jpn"},{"key":"481_CR19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0016-5085(63)80130-4","volume":"44","author":"F Schaffner","year":"1963","unstructured":"Schaffner F, Popper H. Capillarization of hepatic sinusoids in man. Gastroenterology. 1963;44:239\u201342.","journal-title":"Gastroenterology"},{"key":"481_CR20","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1537-2995.2008.01978.x","volume":"49","author":"AK Davis","year":"2009","unstructured":"Davis AK, Makar RS, Stowell CP, Kuter DJ, Dzik WH. ADAMTS13 binds to CD36: a potential mechanism for platelet and endothelial localization of ADAMTS13. Transfusion. 2009;49:206\u201313.","journal-title":"Transfusion"},{"key":"481_CR21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0038-1660099","volume":"54","author":"PG Langley","year":"1985","unstructured":"Langley PG, Hughes RD, Williams R. Increased factor VIII complex in fulminant hepatic failure. Thromb Haemost. 1985;54:693\u20136.","journal-title":"Thromb Haemost"},{"key":"481_CR22","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0168-8278(99)80104-4","volume":"30","author":"L Albornoz","year":"1999","unstructured":"Albornoz L, Alvarez D, Otaso JC, Gadano A, Salviu J, Gerona S, et al. Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels. J Hepatol. 1999;30:451\u20135.","journal-title":"J Hepatol"},{"key":"481_CR23","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.510230613","volume":"23","author":"D Ferro","year":"1996","unstructured":"Ferro D, Quintarelli C, Lattuada A, Leo R, Alessandroni M, Mannucci PM, et al. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia. Hepatology. 1996;23:1377\u201383.","journal-title":"Hepatology"},{"key":"481_CR24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(70)90767-1","volume":"14","author":"MO Rake","year":"1970","unstructured":"Rake MO, Flute PT, Pannell G, Williams R. Intravascular coagulation in acute hepatic necrosis. Lancet. 1970;14:533\u20137.","journal-title":"Lancet"},{"key":"481_CR25","first-page":"470","volume":"21","author":"T Knittel","year":"1995","unstructured":"Knittel T, Neubauer K, Armbrust T, Ramadori G. Expression of von Willebrand factor in normal and diseased rat livers and in cultivated liver cells. Hepatology. 1995;21:470\u20136.","journal-title":"Hepatology"},{"key":"481_CR26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/alcalc\/28.Supplement_1B.77","volume":"1B","author":"S Urashima","year":"1993","unstructured":"Urashima S, Tsutsumi M, Nakase K, Wang JS, Takada A. Studies on capillarization of the hepatic sinusoids in alcoholic liver disease. Alcohol Alcohol Suppl. 1993;1B:77\u201384.","journal-title":"Alcohol Alcohol Suppl"},{"key":"481_CR27","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2004.01.001","volume":"40","author":"L Amitrano","year":"2004","unstructured":"Amitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol. 2004;40:736\u201341.","journal-title":"J Hepatol"},{"key":"481_CR28","first-page":"1238","volume":"21","author":"IR Wanless","year":"1995","unstructured":"Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology. 1995;21:1238\u201347.","journal-title":"Hepatology"},{"key":"481_CR29","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1055\/s-0038-1666894","volume":"42","author":"K Oka","year":"1979","unstructured":"Oka K, Tanaka K. Intravascular coagulation in autopsy cases with liver diseases. Thromb Haemost. 1979;42:564\u201370.","journal-title":"Thromb Haemost"},{"key":"481_CR30","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/blood-2003-08-2861","volume":"103","author":"K Kokame","year":"2004","unstructured":"Kokame K, Matsumoto M, Fujimura Y, Miyata T. VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13. Blood. 2004;103:607\u201312.","journal-title":"Blood"},{"key":"481_CR31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","volume":"129","author":"K Kokame","year":"2005","unstructured":"Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol. 2005;129:93\u2013100.","journal-title":"Br J Haematol"},{"key":"481_CR32","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1538-7836.2007.02438.x","volume":"5","author":"SC Meyer","year":"2007","unstructured":"Meyer SC, Sulzer I, L\u00e4mmle B, Kremer Hovinga JA. Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies. J Thromb Haemost. 2007;5:866\u20137.","journal-title":"J Thromb Haemost"},{"key":"481_CR33","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1537-2995.2006.00914.x","volume":"46","author":"S Kato","year":"2006","unstructured":"Kato S, Matsumoto M, Matsuyama T, Isonishi A, Hiura H, Fujimura Y. Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity. Transfusion. 2006;46:1444\u201352.","journal-title":"Transfusion"},{"key":"481_CR34","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1172\/JCI105380","volume":"45","author":"RH Aster","year":"1966","unstructured":"Aster RH. Pooling of platelets in the spleen: role in the pathogenesis of \u201chypersplenic\u201d thrombocytopenia. J Clin Invest. 1966;45:645\u201357.","journal-title":"J Clin Invest"},{"key":"481_CR35","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1182\/blood.V95.3.795.003k25_795_801","volume":"95","author":"M Peck-Radosavljevic","year":"2000","unstructured":"Peck-Radosavljevic M, Wichlas M, Zacherl J, Stiegler G, Stohlawetz P, Fuchsj\u00e4ger M, et al. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood. 2000;95:795\u2013801.","journal-title":"Blood"},{"key":"481_CR36","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1160\/TH08-01-0006","volume":"99","author":"M Uemura","year":"2008","unstructured":"Uemura M, Fujimura Y, Matsumoto M, Ishizashi H, Kato S, Matsuyama T, et al. Comprehensive analysis of ADAMTS13 in patients with liver cirrhosis. Thromb Haemost. 2008;99:1019\u201329.","journal-title":"Thromb Haemost"},{"key":"481_CR37","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V98.9.2730","volume":"98","author":"PM Mannucci","year":"2001","unstructured":"Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E. Changes in health and disease of the metalloproteinase that cleaves von Willebrand factor. Blood. 2001;98:2730\u20135.","journal-title":"Blood"},{"key":"481_CR38","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1365-2141.2007.06688.x","volume":"138","author":"HB Feys","year":"2007","unstructured":"Feys HB, Canciani MT, Peyvandi F, Deckmyn H, Vanhoorelbeke K, Mannucci PM. ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis. Br J Haematol. 2007;138:534\u201340.","journal-title":"Br J Haematol"},{"key":"481_CR39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","volume":"44","author":"T Lisman","year":"2006","unstructured":"Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, et al. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology. 2006;44:53\u201361.","journal-title":"Hepatology"},{"key":"481_CR40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2141.1987.tb02326.x","volume":"67","author":"AE Schorer","year":"1987","unstructured":"Schorer AE, Moldow CF, Rick ME. Interleukin 1 or endotoxin increases the release of von Willebrand factor from human endothelial cells. Br J Haematol. 1987;67:193\u20137.","journal-title":"Br J Haematol"},{"key":"481_CR41","first-page":"58","volume":"23","author":"I Tornai","year":"1993","unstructured":"Tornai I, H\u00e1rsfalvi J, Boda Z, Udvardy M, Pfliegler G, Rak K. Endothelium releases more von Willebrand factor and tissue-type plasminogen activator upon venous occlusion in patients with liver cirrhosis than in normals. Haemostasis. 1993;23:58\u201364.","journal-title":"Haemostasis"},{"key":"481_CR42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2004-01-0107","volume":"104","author":"A Bernardo","year":"2004","unstructured":"Bernardo A, Ball C, Nolasco L, Moake JF, Dong J. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood. 2004;104:100\u20136.","journal-title":"Blood"},{"key":"481_CR43","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/j.1538-7836.2008.02989.x","volume":"6","author":"WJ Cao","year":"2008","unstructured":"Cao WJ, Niiya M, Zheng XW, Shang DZ, Zheng XL. Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells. J Thromb Haemost. 2008;6:1233\u20135.","journal-title":"J Thromb Haemost"},{"key":"481_CR44","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.febslet.2007.03.029","volume":"581","author":"Y Kume","year":"2007","unstructured":"Kume Y, Ikeda H, Inoue M, Tejima K, Tomiya T, Nishikawa T, et al. Hepatic stellate cell damage may lead to decreased plasma ADAMTS13 activity in rats. FEBS Lett. 2007;581:1631\u20134.","journal-title":"FEBS Lett"},{"key":"481_CR45","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1538-7836.2006.01893.x","volume":"4","author":"M Niiya","year":"2006","unstructured":"Niiya M, Uemura M, Zheng XW, Pollak ES, Dockal M, Scheiflinger F, et al. Increased ADAMTS-13 proteolytic activity in rat hepatic stellate cells upon activation in vitro and in vivo. J Thromb Haemost. 2006;4:1063\u201370.","journal-title":"J Thromb Haemost"},{"key":"481_CR46","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jhep.2004.08.030","volume":"42","author":"M Yagita","year":"2005","unstructured":"Yagita M, Uemura M, Nakamura T, Kunitomi A, Matsumoto M, Fujimura Y. Development of ADAMTS-13 inhibitor in a patient with hepatitis C virus-related liver cirrhosis causes thrombotic thrombocytopenic purpura. J Hepatol. 2005;42:420\u20131.","journal-title":"J Hepatol"},{"key":"481_CR47","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1053\/j.seminhematol.2003.10.009","volume":"41","author":"M Matsumoto","year":"2004","unstructured":"Matsumoto M, Yagi H, Wada H, Fujimura Y. The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Semin Hematol. 2004;41:68\u201374.","journal-title":"Semin Hematol"},{"key":"481_CR48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-2008-1040319","volume":"28","author":"P Tandon","year":"2008","unstructured":"Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis. 2008;28:26\u201342.","journal-title":"Semin Liver Dis"},{"key":"481_CR49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1055\/s-2005-871197","volume":"25","author":"M Sala","year":"2005","unstructured":"Sala M, Forner A, Varela M, Bruix J. Prognostic prediction in patients with hepatocellular carcinoma. Semin Liver Dis. 2005;25:171\u201380.","journal-title":"Semin Liver Dis"},{"key":"481_CR50","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/gut.45.3.435","volume":"45","author":"M Lenzi","year":"1999","unstructured":"Lenzi M, Bellentani S, Saccoccio G, Muratori P, Masutti F, Muratori L, et al. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case\u2013control study of the Dionysos cohort. Gut. 1999;45:435\u201341.","journal-title":"Gut"},{"key":"481_CR51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/jcp.2006.046276","volume":"61","author":"MY Hsieh","year":"2008","unstructured":"Hsieh MY, Dai CY, Lee LP, Huang JF, Tsai WC, Hou NJ, et al. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C. J Clin Pathol. 2008;61:333\u20137.","journal-title":"J Clin Pathol"},{"key":"481_CR52","first-page":"613","volume":"21","author":"BD Clifford","year":"1995","unstructured":"Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology. 1995;21:613\u20139.","journal-title":"Hepatology"},{"key":"481_CR53","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/hep.1840040521","volume":"4","author":"SW French","year":"1984","unstructured":"French SW, Benson NC, Sun PS. Centrilobular liver necrosis induced by hypoxia in chronic ethanol-fed rats. Hepatology. 1984;4:912\u20137.","journal-title":"Hepatology"},{"issue":"1 Suppl","key":"481_CR54","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0168-8278(00)80420-1","volume":"32","author":"CS Lieber","year":"2000","unstructured":"Lieber CS. Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatol. 2000;32(1 Suppl):113\u201328.","journal-title":"J Hepatol"},{"key":"481_CR55","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1046\/j.1440-1746.2003.03217.x","volume":"18","author":"PS Haber","year":"2003","unstructured":"Haber PS, Warner R, Seth D, Gorrell MD, McCaughan GW. Pathogenesis and management of alcoholic hepatitis. Gastroenterol Hepatol. 2003;18:1332\u201344.","journal-title":"Gastroenterol Hepatol"},{"key":"481_CR56","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0168-8278(91)90933-3","volume":"12","author":"H Fukui","year":"1991","unstructured":"Fukui H, Brauner B, Bode JC, Bode C. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol. 1991;12:162\u20139.","journal-title":"J Hepatol"},{"issue":"12 Suppl","key":"481_CR57","doi-asserted-by":"crossref","first-page":"264S","DOI":"10.1097\/01.alc.0000192326.08931.cb","volume":"29","author":"M Uemura","year":"2005","unstructured":"Uemura M, Matsuyama T, Ishikawa M, Fujimoto M, Kojima H, Sakurai S, et al. Decreased activity of plasma ADAMTS13 may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis. Alcohol Clin Exp Res. 2005;29(12 Suppl):264S\u201371S.","journal-title":"Alcohol Clin Exp Res"},{"issue":"1 Suppl","key":"481_CR58","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1111\/j.1530-0277.2006.00283.x","volume":"31","author":"T Matsuyama","year":"2007","unstructured":"Matsuyama T, Uemura M, Ishikawa M, Matsumoto M, Ishizashi H, Kato S, et al. Increased von Willebrand factor over decreased ADAMTS13 activity may contribute to the development of liver disturbance and multiorgan failure in patients with alcoholic hepatitis. Alcohol Clin Exp Res. 2007;31(1 Suppl):S27\u201335.","journal-title":"Alcohol Clin Exp Res"},{"key":"481_CR59","doi-asserted-by":"crossref","unstructured":"Ishikawa M, Uemura M, Matsuyama T, Matsumoto M, Ishizashi H, Kato S, et al. Potential role of enhanced cytokinemia and plasma inhibitor on the decreased activity of plasma ADAMTS13 in patients with alcoholic hepatitis: relationship to endotoxemia. Alcohol Clin Exp Res. 2008; Dec 16 [Epub ahead of print].","DOI":"10.1182\/blood.V112.11.2292.2292"},{"key":"481_CR60","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1160\/TH04-08-0467","volume":"93","author":"RA Reiter","year":"2005","unstructured":"Reiter RA, Varadi K, Turecek PL, Jilma B, Kn\u00f6bl P. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation. Thromb Haemost. 2005;93:554\u20138.","journal-title":"Thromb Haemost"},{"key":"481_CR61","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3324\/haematol.11677","volume":"93","author":"CL Bockmeyer","year":"2008","unstructured":"Bockmeyer CL, Claus RA, Budde U, Kentouche K, Schneppenheim R, L\u00f6sche W, et al. Inflammation-associated ADAMTS13 deficiency promotes formation of ultra-large von Willebrand factor. Haematologica. 2008;93:137\u201340.","journal-title":"Haematologica"},{"key":"481_CR62","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","volume":"85","author":"SI Bearman","year":"1995","unstructured":"Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood. 1995;85:3005\u201320.","journal-title":"Blood"},{"key":"481_CR63","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/hep.1840040121","volume":"4","author":"GB McDonald","year":"1984","unstructured":"McDonald GB, Sharma P, Matthews DE, Shulman HM, Thomas ED. Venoocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology. 1984;4:116\u201322.","journal-title":"Hepatology"},{"key":"481_CR64","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.bmt.1703544","volume":"29","author":"YD Park","year":"2002","unstructured":"Park YD, Yoshioka A, Kawa K, Ishizashi H, Yagi H, Yamamoto Y, et al. Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation. Bone Marrow Transpl. 2002;29:789\u201394.","journal-title":"Bone Marrow Transpl"},{"key":"481_CR65","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/sj.bmt.1705724","volume":"40","author":"M Matsumoto","year":"2007","unstructured":"Matsumoto M, Kawa K, Uemura M, Kato S, Ishizashi H, Isonishi A, et al. Prophylactic fresh frozen plasma may prevent development of hepatic VOD after stem cell transplantation via ADAMTS13-mediated restoration of von Willebrand factor plasma levels. Bone Marrow Transpl. 2007;40:251\u20139.","journal-title":"Bone Marrow Transpl"},{"key":"481_CR66","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00007890-199902270-00009","volume":"67","author":"HM Trimarchi","year":"1999","unstructured":"Trimarchi HM, Truong LD, Brennan S, Gonzalez JM, Suki WN. FK506-associated thrombotic microangiopathy: report of two cases and review of the literature. Transplantation. 1999;67:539\u201344.","journal-title":"Transplantation"},{"key":"481_CR67","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1399-0012.1998.tb01024.x","volume":"12","author":"A Humar","year":"1998","unstructured":"Humar A, Jessurun J, Sharp HL, Gruessner RW. Thrombotic microangiopathy after liver-small bowel transplant. Clin Transpl. 1998;12:600\u20131.","journal-title":"Clin Transpl"},{"key":"481_CR68","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.lts.2003.09.021","volume":"9","author":"Y Nakazawa","year":"2003","unstructured":"Nakazawa Y, Hashikura Y, Urata K, Ikegami T, Terada M, Yagi H, et al. Von Willebrand factor-cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: a case report. Liver Transpl. 2003;9:1328\u201333.","journal-title":"Liver Transpl"},{"key":"481_CR69","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s00134-003-1727-x","volume":"29","author":"C Ben Hamida","year":"2003","unstructured":"Ben Hamida C, Lauzet JY, Rezaiguia-Delclaux S, Duvoux C, Cherqui D, Duvaldestin P, et al. Effect of severe thrombocytopenia on patient outcome after liver transplantation. Intens Care Med. 2003;29:756\u201362.","journal-title":"Intens Care Med"},{"issue":"Suppl 1","key":"481_CR70","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1590\/S0102-86502006000700012","volume":"21","author":"FS Ramalho","year":"2006","unstructured":"Ramalho FS, Fernandez-Monteiro I, Rosello-Catafau J, Peralta C. Hepatic microcirculatory failure. Acta Cir Bras. 2006;21(Suppl 1):48\u201353.","journal-title":"Acta Cir Bras"},{"key":"481_CR71","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/lt.20733","volume":"12","author":"S Ko","year":"2006","unstructured":"Ko S, Okano E, Kanehiro H, Matsumoto M, Ishizashi H, Uemura M, et al. Plasma ADAMTS13 activity may predict early adverse events in living donor liver transplantation: observations in 3 cases. Liver Transpl. 2006;12:859\u201369.","journal-title":"Liver Transpl"},{"key":"481_CR72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1034\/j.1399-0012.1999.t01-2-130104.x","volume":"13","author":"J Basile","year":"1999","unstructured":"Basile J, Busuttil A, Sheiner PA, Emre S, Guy S, Schwartz ME, et al. Correlation between von Willebrand factor levels and early graft function in clinical liver transplantation. Clin Transpl. 1999;13:25\u201331.","journal-title":"Clin Transpl"},{"key":"481_CR73","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/00007890-199809270-00008","volume":"66","author":"K Kiuchi","year":"1998","unstructured":"Kiuchi K, Oldhafer KJ, Schlitt HJ, Nashan B, Deiwick A, Wonigeit K, et al. Background and prognostic implications of perireperfusion tissue injuries in human liver transplants: a panel histochemical study. Transplantation. 1998;66:737\u201347.","journal-title":"Transplantation"},{"key":"481_CR74","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1097\/01.TP.0000100400.82135.DC","volume":"76","author":"W Jassem","year":"2003","unstructured":"Jassem W, Koo DD, Cerundolo L, Rela M, Heaton ND, Fuggle SV. Cadaveric versus living-donor livers: differences in inflammatory markers after transplantation. Transplantation. 2003;76:1599\u2013603.","journal-title":"Transplantation"},{"key":"481_CR75","doi-asserted-by":"crossref","unstructured":"Kobayashi T, Wada H, Usui M, Sakurai H, Matsumoto T, Nobori T, et al. Decreased ADAMTS13 levels in patients after living donor liver transplantation. Thromb Res. 2009; May 5 [Epub ahead of print].","DOI":"10.1016\/j.thromres.2009.03.010"},{"key":"481_CR76","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1600-6143.2009.02621.x","volume":"9","author":"ITA Pereboom","year":"2009","unstructured":"Pereboom ITA, Adelmeijer J, van Leeuwen Y, Hendriks HGD, Porte RJ, Lisman T. Development of a severe von Willebrand factor\/ADAMTS13 dysbalance during orthotopic liver transplantation. Am J Transpl. 2009;9:1189\u201396.","journal-title":"Am J Transpl"},{"key":"481_CR77","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1172\/JCI112843","volume":"79","author":"SD Berkowitz","year":"1987","unstructured":"Berkowitz SD, Dent J, Roberts J, Fujimura Y, Plow EF, Titani K, et al. Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin. J Clin Invest. 1987;79:524\u20135.","journal-title":"J Clin Invest"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0481-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-009-0481-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0481-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,16]],"date-time":"2025-02-16T13:43:30Z","timestamp":1739713410000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-009-0481-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["481"],"URL":"https:\/\/doi.org\/10.1007\/s12185-009-0481-4","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}